Compare EVO & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | TWO |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Germany | United States |
| Employees | 4553 | 486 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 934.1M | 1.3B |
| IPO Year | N/A | N/A |
| Metric | EVO | TWO |
|---|---|---|
| Price | $2.79 | $12.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 7 |
| Target Price | $7.00 | ★ $12.56 |
| AVG Volume (30 Days) | 91.4K | ★ 2.4M |
| Earning Date | 04-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $8.84 |
| 52 Week High | $4.80 | $14.17 |
| Indicator | EVO | TWO |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 66.69 |
| Support Level | $2.63 | $9.53 |
| Resistance Level | $3.78 | $12.70 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 31.14 | 66.92 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.